"UCSF's Got Talent" Competition Returns May 10
University of California San Francisco
Give to UCSF
Displaying 11101 - 11130 of 16507
-
-
On 'Grey's Anatomy,' an Altruistic Act in Alzheimer's Study Could Wreak Havoc
-
50 Most Influential Physician Executives for 2011
-
A Spoonful of Sugar.... is Toxic?
-
UCSF's Support Group for Parents of Intersex Kids
-
UCSF Stem Cell Studies to Focus on Muscular Dystrophy, Heart Disease, Cancer
Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine why human embryonic stem cells are susceptible to forming tumors.
-
UCSF Heart Doctors Uncover Significant Bias in Taser(r) Safety Studies
The ongoing controversy surrounding the safety of using TASER® electrical stun guns took a new turn today when a team of cardiologists at the University of California, San Francisco announced findings suggesting that much of the current TASER®-related safety research may be biased due to ties to the devices’ manufacturer, TASER International, Inc.
-
Drug Makers Seeking Global Guinea Pigs
-
Media Advisory: UCSF to Offer Free Skin Cancer Screenings in Chinatown
The UCSF Department of Dermatology, in partnership with the San Francisco Board of Supervisors and the Chinatown Public Health Clinic, will offer free skin cancer screenings in Chinatown to mark National Skin Cancer Awareness Month.
-
UCSF Scientists Play Key Role in Success of Yervoy, a New Cancer Drug
<p>Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.</p>
-
Cardiac Arrest Less Deadly in Exercise Facilities, Study Finds
-
Hospitals Work to Reduce Emergency-Room Wait Times
-
UCSF Botulism Research Translates Into Bioterrorism Treatment
<p>UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.</p>
-
UCSF Pushes the Frontiers of Knowledge of Cardiovascular Biology and Disease
<p>Blending state-of-the art technology and cutting-edge design, UCSF’s new cardiovascular research building at Mission Bay integrates basic and clinical research to address important questions in cardiovascular biology and disease. </p>
-
Read It and Weep, Crybabies
-
Santa Cruz Skateboards Comes Up with New Deck for Kids with Cancer
-
Smithsonian: 30 Years Of HIV/AIDS
-
All You Need is Love
-
Legal Barriers to Wide HIV Testing Now Mostly Gone
-
New Faculty: Jeffrey D. Edwards
May 2011
-
Hysterectomy 'Lowers Ovarian Cancer Risk'
-
UCSF Scientists Honored by National Academy of Sciences
Alexander D. Johnson, PhD, and Shinya Yamanaka, MD, PhD, have been elected as members of the National Academy of Sciences (NAS) for their excellence in original scientific research.
-
A Drug Used for Maintenance Treatment of Bipolar Disorder Lacks Evidence, Scientists Contend
-
Search Your Doctor: Study Finds Oversight Lacking in CA
-
Sugar as a Potential Health Risk is Getting a Closer Look
<p>Sugar is a poison, and conventional thinking about the role of hormones in metabolism is wrong, according to UCSF pediatrician Robert Lustig. His work is gaining attention in the mainstream media. </p>
-
Letter to the Editor: Help for Patients with ALS
-
Ray and Dagmar Dolby Regeneration Medicine Building
-
Education Day Showcases Scholarly Work
<p><span class="Apple-style-span">Interprofessional education was a recurring theme at UCSF's Education Day when scholars from all four professional schools showcased their work and discussed how to change and adapt teaching in ways that transcend traditional boundaries.</span></p>
-
Massive Clean Up is No Cure for Hoarding
-
Lawrence H. Diller's New Book on Ritalin